van der Baan Bastiaan Jeroen 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
van der Baan Bastiaan Jeroen
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-12-30$4.90/sh+10,000$49,000→ 10,000 total
Signature
/s/ Bastiaan van der Baan|2023-01-03